EKF Diagnostics (LON:EKF – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported GBX 0.54 EPS for the quarter, Digital Look Earnings reports. EKF Diagnostics had a net margin of 4.86% and a return on equity of 3.58%.
EKF Diagnostics Stock Up 2.2%
LON EKF traded up GBX 0.56 on Thursday, reaching GBX 25.56. The stock had a trading volume of 355,551 shares, compared to its average volume of 326,592. The company has a current ratio of 4.72, a quick ratio of 1.77 and a debt-to-equity ratio of 2.09. EKF Diagnostics has a 1 year low of GBX 22 and a 1 year high of GBX 31.70. The business has a 50 day moving average price of GBX 25.43 and a 200 day moving average price of GBX 25.50. The company has a market capitalization of £109.44 million, a price-to-earnings ratio of 54.38 and a beta of 0.50.
About EKF Diagnostics
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
See Also
- Five stocks we like better than EKF Diagnostics
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
